Screener
aTyr Pharma ATYR Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from aTyr Pharma’s reported figures.
Based on trailing twelve months.
The source filing: aTyr Pharma’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001339970-26-000053
FAQ
- What is aTyr Pharma's return on equity?
- aTyr Pharma (ATYR) reported return on equity of -98.4% in Q2 2026.
- How has aTyr Pharma's return on equity changed year-over-year?
- aTyr Pharma's return on equity decreased by 15.5% year-over-year, from -85.2% to -98.4%.
- What is the long-term trend for aTyr Pharma's return on equity?
- Over 5 years (2020 to 2025), aTyr Pharma's return on equity has grown at a 11.9% compound annual growth rate (CAGR), from -61.4% to -107.8%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about aTyr Pharma's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude